Ledger.Open graph →
SEC Form D · filed January 6, 2022

Pluto Immunotherapeutics, Inc

Offering
$3.0M
Sold
$2.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LOS ANGELES, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Mark Cohen · Washington, Washington, D.C.DirectorAmelie Montel-Hagen · Los Angeles, CAExec · DirectorChristopher Seet · Los Angeles, CADirectorGay Crooks · Los Angeles, CADirectorMark Cohen · London, United KingdomDirectorAmelie Montel-Hagen · Los Angeles, CAExec · DirectorChristopher Seet · Los Angeles, CADirectorGay Crooks · Los Angeles, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗